Weitzman ECHO Series for Ohio: Substance Use Disorders 2024-2025

Weitzman ECHO Substance Use Disorders:

Managing Patients with Substance Use Disorders in Primary Care

Program Information

This Weitzman ECHO Series for Ohio connects primary care providers, behavioral health providers, and other care team members to a community of peers and subject matter experts from across Ohio to address patients’ complex health needs related to substance use disorders. The multidisciplinary faculty team applies a trauma-informed, harm-reduction philosophy of care to improve the care of patients with substance use disorders and their health outcomes.

Weitzman ECHO Substance Use Disorders 2024-2025 is the continuing education series' third cohort that includes 20 sessions over a span of 10 months. The series begins Monday, October 7th, 2024, and is offered in collaboration with Buckeye Health Plan and Ohio University at no cost. Each one-hour ECHO session consists of a brief didactic presentation on key topics related to substance use disorders followed by patient case discussions submitted by participating providers.

CME, CNE, CPE, and CEU credits will be provided for physicians, nurse practitioners, nurses, physician associates/assistants, pharmacists, social workers, and psychologists by Moses/Weitzman Health System, Inc., an accredited provider through Joint Accreditation for Interprofessional Continuing Education.

Acknowledgement of Support

This program is supported by Ohio’s Medicaid Managed Care Plans' community reinvestment initiatives through the 2023 Collaborative Medicaid Managed Care Community Reinvestment Fund. This fund is administered by the Ohio Association of Health Plans.

Target Audience

This activity is appropriate for the following audiences:

Primary care providers (MD, DO, NP, PA)
Behavioral health providers
Other members of the care team

Learning Objectives

Upon completion of this activity, participants should be able to do the following:

Project a harm reduction philosophy of care into your treatment of patients experiencing substance use disorders and explain this concept to peers
Illustrate trauma-informed practices in the screening, assessment, and treatment of patients experiencing substance use disorders
Optimize the care of common co-occurring psychiatric and medical conditions in patients experiencing substance use disorders
[For prescribers] Enhance clinical competence and confidence around medication management for patients with substance use disorders, including alcohol, stimulants, opioid, cannabis, and tobacco.
[For non-prescribers] Understand the importance and provide support for medication management strategies in patients experiencing substance use disorders, including alcohol, stimulants, opioid, cannabis, and tobacco.
Use motivational interviewing and other behavioral techniques to improve patient outcomes related to substance use disorders
Collaborate with community clinical and non-clinical care team members more effectively to improve the management of patients, including those experiencing polysubstance use.
Distinguish and address factors related to social determinants of health faced by specific populations experiencing substance use disorders

FAQs

What is Project ECHO®? Project ECHO® was developed by Sanjeev Arora, MD, at the University of New Mexico Health Sciences Center and is a collaborative model of medical education and care management that helps improve clinicians' knowledge and skills to improve patient care. ECHOs are designed to be a longer-term continuing education programs to create a virtual community for providers and care team members to connect and learn from leading experts and receive guidance from peers and experts. This ECHO learning community provides mentorship and peer support, making this model unique and providing long-lasting impact beyond typical e-learning styles. Weitzman ECHO clinics are specifically designed to meet the needs of safety net primary care providers and their communities like providers practicing in federally qualified health centers (FQHCs).

How is each ECHO session structured? Each ECHO session consists of a didactic presentation by the ECHO's expert faculty and real patient case discussion presented by participating providers. During each ECHO session, participants learn skills and receive clinical pearls from the expert faculty didactic presentation and the case discussion and recommendations.

How much does it cost to participate? Enrollment is now open at no cost for the next curriculum year.

Who should participate? Primary care medical providers, behavioral health providers, and care team members who work in Ohio (or in an Appalachian region in a bordering state) are welcome to join and register.

When do sessions occur? This Project ECHO will occur twice monthly for one hour. Our kickoff session for our first module will occur on October 7, 2024, and sessions will occur every 1st and 3rd Monday of each month from 12pm to 1pm ET.

What level of participation is expected? Substance Use Disorders ECHO consists of 24 sessions in total. ECHO participants are expected to:

Attend at least 50% of sessions
Complete pre- and post- surveys
Submit at least one case for recommendations
Share webcams, when available
Engage during peer case discussion

How do I join the live sessions? Do I need any special equipment? Weitzman ECHO sessions are held virtually using the Weitzman Education Platform and Zoom Video Conferencing. Access is available on any computer with an internet connection. For instruction on how to how to join the live session, follow these Step-by-step instructions: Entering a Live Session.

How do I claim credit and download my CE/CME certificate? After the live session is completed, the session evaluation will be available right in the platform. Once you complete the session evaluation, you will be able to claim your credits and download your certificate.

AMA Designation Statement

Moses/Weitzman Health System Inc. designates this Live activity for a maximum of 20 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity summary

Available credit:

20.00 AAPA Category I CME
Through Joint Accreditation, Moses/Weitzman Health Center, Inc./Weitzman Institute is able to provide American Academy of PAs (AAPA) credit to physician assistants at its activities. Participants should only claim commensurate credit with the extent of their participation in the activity.
20.00 ACE/ASWB
Through Joint Accreditation Moses/Weitzman Health Center, Inc./Weitzman Institute is able to provide Association of Social Work Boards (ASWB) credit to social workers at its activities.
20.00 ACPE
Through Joint Accreditation, Moses/Weitzman Health Center, Inc./Weitzman Institute is able to provide Accreditation Council for Pharmacy Education (ACPE) credit to pharmacists at its activities.
20.00 AMA PRA Category 1 Credit™
Through Joint Accreditation, Moses/Weitzman Health Center, Inc./Weitzman Institute is able to provide AMA PRA Category 1 Credit™ to physicians at its activities via Accreditation Council for Continuing Medical Education (ACCME).
20.00 ANCC
Through Joint Accreditation, Moses/Weitzman Health Center, Inc./Weitzman Institute is able to provide American Nurses Credentialing Center (ANCC) nursing credit to nurses at its activities.
20.00 APA
Through Joint Accreditation, Moses/Weitzman Health Center, Inc./Weitzman Institute is able to provide American Psychological Association (APA) credit to psychologists at its activities.
20.00 Participation Hour(s)
If you are not able to utilize any of the above credit types, you are able to download an unaccredited Participation Certificate for your records.

Activity opens:

08/24/2024

Activity expires:

08/15/2025

Schedule

This activity meets the 1st & 2nd Monday of every month from 12-1pm ET. Below are the dates of the sessions:

Module 1: SUD Care Strategies - A Foundation for Primary Care

October 7, 2024
October 14, 2024
November 4, 2024
November 11, 2024
December 2, 2024
December 9, 2024
January 6, 2025
January 13, 2025

Module 2: MAT

February 3, 2025
February 10, 2025
March 3, 2025
March 10, 2025
April 7, 2025

Module 3: SUD Comorbidities

April 14, 2025
May 5, 2025
May 12, 2025
June 2, 2025
June 9, 2025
July 7, 2025
July 14, 2025

Faculty

Mark Hurst, MD has a rich history in the healthcare field. During his career, Hurst has held leadership positions in the private sector, public sector and state government, including as medical director and director of the Ohio Department of Mental Health and Addiction Services and medical director and assistant director of the Ohio Department of Health. In his state positions, he led efforts in suicide prevention, dual diagnosis treatment, trauma informed care, and addressing the opioid crisis. Dr. Hurst is board-certified in psychiatry and addiction psychiatry is a private healthcare consultant and is Clinical Associate Professor of Psychiatry and Behavioral Health at The Ohio State University. He has been recognized by his peers as a "Best Doctor in America" on multiple occasions.

Dana Vallangeon, MD most recently completed over five years at OACHC as the Chief Medical Officer. As CMO, she assisted in efforts to lead health center clinical teams to the highest levels of quality and operational efficiency. Her dual board certification in Family Medicine and Addiction Medicine supported her work with the OACHC Behavioral Health and Quality teams to continue the adoption of effective Substance Use Disorder treatment throughout Ohio’s FQHCs. A former health center CEO and staff physician for over 17 years, she has also been a medical director at a free clinic and at a substance use disorder/mental health treatment facility, along with an ongoing role as an adjunct medical school and Family Medicine residency faculty. She received her M.D. degree from The Ohio State University College of Medicine and her B.S. degree from Olivet Nazarene University.

Ericka Ludwig, DHS, LPCC-S, LICDC-CS earned her Bachelor’s Degree in Psychology from Capital University, her Master’s Degree in Clinical Mental Health Counseling from Wright State University, and her Doctorate Degree in Human Services from Capella University. For the last 11 years, Ericka has been employed at Hopewell Health Centers located in the beautiful Hocking Hills, Ohio, providing direct clinical care to clients who have co-occurring mental health and substance use concerns. In her current role as the Outpatient Supervisor/Coordinator of counseling services, she provides both direct care to a small case load of clients as well as provides clinical and administrative supervision of counseling staff. Her passion for this population can be displayed through her involvement in innovative programs addressing rural substance use concerns including the Hocking County Municipal Court Drug Court programs, Rapid Access, Project HOPE, and recovery housing. She was awarded the 2015 Hocking County Mental Health Advocate Award for her leadership on the creation of the county’s first recovery house.

Kate Berenson, MD, FACP, FASAM, graduated from the Wright State Boonshoft School of Medicine and initially pursued psychiatry before transitioning to internal medicine, completing her chief year in 2018 along with an HRSA fellowship in Primary Care Transformations. While her passion for outpatient care remained strong, she developed a keen interest in studying and developing treatments for substance use disorders. The pandemic, unexpectedly, provided her with the opportunity to focus on this area. She completed an addiction fellowship at OhioHealth in 2021 and subsequently established the MAT program at Five Rivers Health Center, a Federally Qualified Health Center (FQHC) in Dayton, Ohio. The program integrates peer support, group therapy, and pharmacotherapy to address the full spectrum of substance use disorders, while also incorporating primary care and infectious disease management, including Hepatitis C treatment, to provide holistic care. She is pleased to contribute her insights and evidence-based perspectives to the Weitzman ECHO series.

Weitzman Institute Disclosure Statement

It is the policy of the Weitzman Institute to ensure that Continuing Education (CE) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the Weitzman Institute requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

Faculty participating in a Weitzman Institute-sponsored activity must disclose to the planning committee and audience all financial or other relationship(s) with ineligible companies.

Planner(s)